JOHN LYERLY: Open Payments
NPI 1952965733 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| Janssen Pharmaceuticals, Inc | 1 | $81 |
| E.R. Squibb & Sons, L.L.C. | 1 | $78 |
| Teva Pharmaceuticals USA, Inc. | 1 | $76 |
| Neurocrine BioSciences, Inc. | 1 | $71 |
| Tactile Systems Technology Inc | 1 | $22 |
Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, UZEDY, INGREZZA, Flexitouch Plus.
Industry payments across NY — which companies pay providers there.
